Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression

This study has been completed.

Sponsor:

National Center for Complementary and Integrative Health (NCCIH)

ClinicalTrials.gov Identifier:

NCT00090506

First Posted: August 27, 2004

Last Update Posted: January 25, 2008

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.

Further study details as provided by National Center for Complementary and Integrative Health (NCCIH):

Estimated Enrollment:

50

Study Start Date:

July 2004

Study Completion Date:

March 2007

Primary Completion Date:

March 2007 (Final data collection date for primary outcome measure)

Detailed Description:

In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.

Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

14 Years to 40 Years (Child, Adult)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria for Study 1 Participants:

Meet certain laboratory requirements

Inclusion Criteria for Study 2 Participants:

HIV infected

Able to walk at least 50% of the time

Inclusion Criteria for All Participants:

Written informed consent of parent/guardian, if applicable

Exclusion Criteria for Study 2 Participants:

Require antiretroviral therapy

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00090506